Medicare Enrolled
Dr. David Pan, M.D., FACC
Cardiovascular Disease · Orange, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pan
Dr. David Pan is a cardiovascular disease specialist in Orange, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Pan performed 1,201 Medicare services across 847 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pan received a total of $53,904 from 48 pharmaceutical and/or device companies across 639 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ 1,201 Medicare services
$53,904 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,201
Medicare services
Bottom 38% in CA for cardiovascular disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
847
Unique beneficiaries
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~63 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
557 | $96 | $345 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
96 | $65 | $230 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
88 | $44 | $154 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
67 | $66 | $185 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
65 | $117 | $447 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
61 | $5 | $22 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
56 | $11 | $39 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
53 | $122 | $573 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
40 | $159 | $566 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
33 | $72 | $245 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
21 | $20 | $70 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
20 | $192 | $663 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
18 | $101 | $394 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
14 | $109 | $350 |
| Cardiac catheterization | 12 | $236 | $2,585 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.3% high complexity
7.6% medium
80.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$53,904
Total received (2018-2024)
Avg $7,701/year across 7 years
Top 9% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
639
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$34,408 (63.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,496 (36.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,852
2023
$9,740
2022
$13,750
2021
$14,843
2020
$4,252
2019
$5,077
2018
$3,392
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$389
Novartis Pharmaceuticals Corporation
$345
Medtronic, Inc.
$315
E.R. Squibb & Sons, L.L.C.
$250
Abbott Laboratories
$232
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$220
Amgen Inc.
$194
Edwards Lifesciences Corporation
$174
Merck Sharp & Dohme LLC
$155
Alnylam Pharmaceuticals Inc.
$123
Lexicon Pharmaceuticals, Inc.
$119
SCPHARMACEUTICALS INC.
$104
Janssen Pharmaceuticals, Inc
$66
Actelion Pharmaceuticals US, Inc.
$52
HEARTFLOW, INC.
$40
Regeneron Healthcare Solutions, Inc.
$30
PFIZER INC.
$24
AstraZeneca Pharmaceuticals LP
$19
Top 3 companies account for 36.8% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$34,703
Abbott Laboratories
$5,077
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$1,442
Novartis Pharmaceuticals Corporation
$1,303
Medtronic, Inc.
$1,271
Medtronic Vascular, Inc.
$1,251
E.R. Squibb & Sons, L.L.C.
$1,235
Amgen Inc.
$1,084
SANOFI-AVENTIS U.S. LLC
$1,048
Boehringer Ingelheim Pharmaceuticals, Inc.
$843
BIOTRONIK INC.
$528
PFIZER INC.
$418
Merck Sharp & Dohme LLC
$397
Amarin Pharma Inc.
$332
Alnylam Pharmaceuticals Inc.
$290
Regeneron Healthcare Solutions, Inc.
$261
Bardy Diagnostics, Inc.
$253
Impulse Dynamics (USA) Inc.
$175
Edwards Lifesciences Corporation
$174
Kestra Medical Technology Services, Inc.
$155
Baxter Healthcare
$152
AstraZeneca Pharmaceuticals LP
$150
Actelion Pharmaceuticals US, Inc.
$148
Boston Scientific Corporation
$146
HeartFlow, Inc.
$133
Kiniksa Pharmaceuticals, Ltd.
$127
SCPHARMACEUTICALS INC.
$126
Bayer HealthCare Pharmaceuticals Inc.
$120
Lexicon Pharmaceuticals, Inc.
$119
BOSTON SCIENTIFIC CORPORATION
$57
Astellas Pharma US Inc
$52
HEARTFLOW, INC.
$40
Novo Nordisk Inc
$34
Kowa Pharmaceuticals America, Inc.
$27
Allergan Inc.
$24
CMP Pharma, Inc.
$23
Otsuka America Pharmaceutical, Inc.
$22
Lundbeck LLC
$22
GlaxoSmithKline, LLC.
$20
PORTOLA PHARMACEUTICALS, INC.
$19
Nevro Corp.
$16
CARDIVA MEDICAL, INC.
$14
CVRx, Inc.
$13
Esperion Therapeutics, Inc.
$13
Gilead Sciences, Inc.
$13
Cranial Technologies, Inc
$12
AtriCure, Inc.
$11
Merck Sharp & Dohme Corporation
$11
Top 3 companies account for 76.5% of all-time payments
Associated products mentioned in payments ›
AMVUTTRA · ANDEXXA · ASSURITY · AVEIR · AZURE XT DR MRI SURESCAN · Advisa · Allure CRT Pacemaker · Allure Quadra RF CRT Pacemaker · Amplia MRI · Arcalyst · Assure WCD · Assurity Pacemaker · Azure · BEVYXXA · BEXSERO · BIOMONITOR · BREATHTEK · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · CHANTIX · CONFIRM RX · CardioMEMS HF System · Carnation Ambulatory Monitor · Carospir · Confirm Rx · Corlanor · Doc Band · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMBLEM · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVKEEZA · Ellipse ICD · FARXIGA · FFRct · FUROSCIX · Fortify Assura · GENERAL TACHY · GENERAL TACHY · GENERAL BRADY · HeartMate 3 Left Ventricular Assist Device · Hillrom - Cardiac Ambulatory Monitor · Hillrom - Carnation Ambulatory Monitor · INVOKANA · Inpefa · JANUVIA · JARDIANCE · JOT DX · Kerendia · LEQVIO · LEXISCAN · LINQ II · LifeVest · Livalo · MICRA · MITRACLIP · MODELS · MULTAQ · MYRBETRIQ · Micra · Mitra Clip system · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · OPTIMIZER · Optimizer · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PRESSUREWIRE · Quadra Assura CRT Defibrillator · REVEAL LINQ · Repatha · Reveal LINQ · Rivacor · Senza Spinal Cord Stimulation System · TRADJENTA · Tendril Pacing Lead · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · Victoza · WAINUA · WINREVAIR · XARELTO · Zero Gravity
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (64%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for cardiovascular disease in CA.
Geographic Context
Cardiologists within 10 mi
332
Per 100K population
10.5
County median income
$113,702
Nearest hospital
PROVIDENCE ST. JOSEPH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pan is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 9% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Pan performed 557 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pan receive payments from pharmaceutical companies?
Yes. Dr. Pan received a total of $53,904 from 48 companies across 639 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pan's costs compare to other cardiologists in Orange?
Dr. Pan's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Orange
Browse cardiologists in Orange ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology